doi: 10.1128/JVI.70.11.8234-8240.1996.
Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy
Affiliations
- PMID: 8892960
- PMCID: PMC190909
- DOI: 10.1128/JVI.70.11.8234-8240.1996
Item in Clipboard
Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy
J Virol.
1996 Nov.
Abstract
We have constructed new murine leukemia virus (MLV)-based vectors (TIN vectors) which, following integration, contain human immunodeficiency virus (HIV) type 1 U3 and R sequences in place of the MLV U3 and R regions. This provides, for the first time, single transcriptional unit retroviral vectors under the control of Tat. TIN vectors have several advantages for anti-HIV gene therapy applications.
Similar articles
-
Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein.J Virol. 1991 Aug;65(8):4490-3. doi: 10.1128/JVI.65.8.4490-4493.1991. J Virol. 1991. PMID: 1649343 Free PMC article.
-
The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.Hum Gene Ther. 1993 Oct;4(5):625-34. doi: 10.1089/hum.1993.4.5-625. Hum Gene Ther. 1993. PMID: 8280800
-
Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.Hum Gene Ther. 1992 Oct;3(5):461-9. doi: 10.1089/hum.1992.3.5-461. Hum Gene Ther. 1992. PMID: 1329991
-
The tat gene and protein of the human immunodeficiency virus type 1.New Microbiol. 1995 Jan;18(1):87-110. New Microbiol. 1995. PMID: 7760763 Review. No abstract available.
-
Lentiviral vectors for gene therapy of HIV-1 infection.Curr Gene Ther. 2002 Feb;2(1):23-43. doi: 10.2174/1566523023348165. Curr Gene Ther. 2002. PMID: 12108972 Review.
Cited by
-
Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector.J Virol. 1998 Feb;72(2):1699-703. doi: 10.1128/JVI.72.2.1699-1703.1998. J Virol. 1998. PMID: 9445081 Free PMC article.
-
XPB mediated retroviral cDNA degradation coincides with entry to the nucleus.Virology. 2011 Feb 20;410(2):291-8. doi: 10.1016/j.virol.2010.11.016. Epub 2010 Dec 17. Virology. 2011. PMID: 21167544 Free PMC article.
-
Is gene therapy a good therapeutic approach for HIV-positive patients?Genet Vaccines Ther. 2007 Feb 14;5:5. doi: 10.1186/1479-0556-5-5. Genet Vaccines Ther. 2007. PMID: 17300725 Free PMC article.
-
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10057-62. doi: 10.1073/pnas.94.19.10057. Proc Natl Acad Sci U S A. 1997. PMID: 9294162 Free PMC article.
-
Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.J Virol. 2003 Apr;77(8):4722-30. doi: 10.1128/jvi.77.8.4722-4730.2003. J Virol. 2003. PMID: 12663779 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
